Benzinga's Top Upgrades, Downgrades For July 14, 2017

Top Upgrades

• Analysts at JP Morgan upgraded Boeing Co BA from Neutral to Overweight. Boeing shares rose 0.83 percent to $207.94 in pre-market trading.
• Needham upgraded Cornerstone OnDemand, Inc. CSOD from Buy to Strong Buy. Cornerstone OnDemand shares gained 1.06 percent to $37.10 in pre-market trading.
• JP Morgan upgraded HD Supply Holdings Inc HDS from Neutral to Overweight. HD Supply shares rose 2.55 percent to close at $30.21 on Thursday.
• Analysts at Telsey Advisory Group upgraded Ross Stores, Inc. ROST from Market Perform to Outperform. Ross Stores shares rose 1.07 percent to $55.00 in pre-market trading.
• Analysts at Goldman Sachs upgraded Ulta Beauty Inc ULTA from Neutral to Conviction Buy. Ulta Beauty shares rose 1.47 percent to $261.18 in pre-market trading.
• Goldman Sachs upgraded Wal-Mart Stores Inc WMT from Neutral to Conviction Buy. Wal-Mart shares gained 1.60 percent to $76.25 in pre-market trading.
• Canaccord Genuity upgraded BJ's Restaurants, Inc. BJRI from Hold to Buy. BJ's Restaurants shares fell 2.07 percent to close at $35.40 on Thursday.
• Analysts at KeyBanc upgraded Magellan Health Inc MGLN from Sector Weight to Overweight. Magellan Health shares climbed 6.01 percent to close at $77.65 on Thursday.

Top Downgrades

• Piper Jaffray downgraded F5 Networks, Inc. FFIV from Overweight to Neutral. F5 Networks shares fell 3.34 percent to $124.00 in after-hours trading.
• JP Morgan downgraded Cyberark Software Ltd CYBR from Overweight to Neutral. CyberArk shares dropped 19.80 percent to $40.90 in pre-market trading.
• KeyBanc downgraded A10 Networks Inc ATEN from Overweight to Sector Weight. A10 Networks shares fell 16.87 percent to $6.85 in pre-market trading.
• Analysts at Deutsche Bank downgraded East West Bancorp, Inc. EWBC from Buy to Hold. East West Bancorp shares rose 0.34 percent to close at $58.46 on Thursday.
• Analysts at Cowen & Co. downgraded Snap Inc SNAP from Outperform to Market Perform. Snap shares fell 2.17 percent to $15.35 in pre-market trading.
• Goldman Sachs downgraded At Home Group Inc HOME from Buy to Neutral. At Home shares gained 0.86 percent to close at $23.48 on Thursday.
• Oppenheimer downgraded Himax Technologies, Inc. (ADR) HIMX from Perform to Underperform. Himax Technologies shares fell 4.87 percent to $7.62 in pre-market trading.
• SunTrust Robinson Humphrey downgraded Kratos Defense & Security Solutions, Inc KTOS from Buy to Hold. Kratos Defense shares dropped 3.65 percent to $12.40 in pre-market trading.
• Bank of America downgraded Avnet, Inc. AVT from Neutral to Underperform. Avnet shares fell 1.13 percent to $39.34 in pre-market trading.
• Raymond James downgraded Summit Hotel Properties Inc INN from Outperform to Market Perform. Summit Hotel Properties shares dropped 0.27 percent to close at $18.21 on Thursday.

Top Initiations

• BTIG Research initiated coverage of Eiger Biopharmaceuticals Inc EIGR with a Buy rating. The price target for Eiger Biopharmaceuticals is set to $32. Eiger Biopharmaceuticals shares closed at $7.45 on Thursday.
• Analysts at CL King initiated coverage on Neogen Corporation NEOG with a Neutral rating. Neogen shares closed at $68.05 on Thursday.
• Oppenheimer initiated coverage on Woodward Inc WWD with an Outperform rating. The price target for Woodward is set to 82. Woodward shares closed at $67.48 on Thursday.
• SunTrust Robinson Humphrey initiated coverage on Affimed NV AFMD with a Buy rating. The price target for Affimed is set to $7. Affimed shares closed at $2.40 on Thursday.
• Analysts at Rosenblatt initiated coverage on News Corp NWSA with a Buy rating. The price target for News Corp is set to $17. News Corp shares closed at $13.23 on Thursday.
• Analysts at JP Morgan initiated coverage on The GEO Group Inc GEO with an Overweight rating. The price target for GEO Group is set to $35. GEO Group shares closed at $29.93 on Thursday.
• Janney Capital initiated coverage on Supernus Pharmaceuticals Inc SUPN with a Neutral rating. The price target for Supernus Pharmaceuticals is set to $47. Supernus Pharmaceuticals shares closed at $44.05 on Thursday.
• SunTrust Robinson Humphrey initiated coverage on Editas Medicine Inc EDIT with a Hold rating. The price target for Editas Medicine is set to $17. Editas Medicine shares closed at $17.71 on Thursday.